La Figure S1 de LP-184, une nouvelle molécule d'acylfulvène, présente une activité anticancéreuse contre divers tumeurs solides avec déficience en recombinaison homologue

Kulkarni et al. (Mon,) ont étudié cette question.

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Supplementary Figure S1 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
2. 2Supplementary Figure S11 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
3. 3Supplementary Figure S11 from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
4. 4Supplementary Figure S6. from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024
5. 5Supplementary Figure S6. from LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency2024